Emcure Pharmaceuticals Limited (NSE: EMCURE)

Emcure Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	1,871	1,690	2,423	1,628	4,687	1,287
Short-Term Investments	452.9	2,997	2,045	-	148.4	350.94
Cash & Short-Term Investments	2,324	4,687	4,468	1,628	4,836	1,638
Cash Growth	-57.14%	4.88%	174.38%	-66.32%	195.16%	57.10%
Accounts Receivable	20,295	18,588	16,483	13,085	14,754	11,452
Other Receivables	993.96	689.48	703.62	461.91	124.13	111.84
Receivables	21,289	19,278	17,187	13,547	14,878	11,564
Inventory	17,516	15,891	14,593	15,593	15,525	12,258
Prepaid Expenses	-	304.41	198.6	330.53	160.49	174.83
Other Current Assets	3,430	2,440	1,912	3,142	1,776	1,395
Total Current Assets	44,558	42,599	38,359	34,241	37,175	27,031
Property, Plant & Equipment	23,807	23,972	22,148	19,855	19,332	19,741
Long-Term Investments	185.49	186.94	557.78	440.37	10.99	132.59
Goodwill	3,823	3,787	2,177	2,174	3,975	3,892
Other Intangible Assets	6,206	5,078	1,258	1,614	3,832	5,036
Long-Term Deferred Tax Assets	1,066	967.96	991.26	1,161	1,483	2,008
Other Long-Term Assets	1,599	1,471	1,234	1,150	2,267	1,942
Total Assets	81,245	78,062	66,725	60,635	68,074	60,041
Accounts Payable	15,069	13,094	10,861	11,252	9,722	7,407
Accrued Expenses	406.17	3,366	2,782	2,457	2,612	3,284
Short-Term Debt	-	9,486	11,333	10,866	12,542	12,712
Current Portion of Long-Term Debt	6,578	3,721	3,175	2,797	3,623	3,452
Current Portion of Leases	306.46	319.19	241.9	222.96	324.43	297.23
Current Income Taxes Payable	886.4	534.45	487.75	621.52	616.91	543.3
Current Unearned Revenue	-	343.42	178.65	271.39	367.07	50.36
Other Current Liabilities	5,074	1,241	1,132	1,160	4,274	1,454
Total Current Liabilities	28,321	32,105	30,192	29,648	34,082	29,198
Long-Term Debt	2,840	7,666	7,441	7,173	7,040	5,533
Long-Term Leases	2,163	2,157	1,152	1,113	1,168	1,274
Long-Term Unearned Revenue	161.16	403.08	307.32	393.7	456.02	127.47
Long-Term Deferred Tax Liabilities	1,319	1,374	388.95	426.14	398.83	440.03
Other Long-Term Liabilities	3,407	3,139	747.37	739.54	1,249	3,624
Total Liabilities	38,212	46,844	40,229	39,493	44,394	40,197
Common Stock	1,891	1,812	1,809	1,809	1,809	1,809
Additional Paid-In Capital	-	98.84	-	-	840.37	840.37
Retained Earnings	-	26,980	22,789	17,751	19,191	15,417
Comprehensive Income & Other	39,293	632.25	413.54	315.91	890.31	1,054
Total Common Equity	41,184	29,523	25,011	19,875	22,730	19,120
Minority Interest	1,850	1,695	1,485	1,266	949.92	724.14
Shareholders' Equity	43,033	31,218	26,497	21,141	23,680	19,844
Total Liabilities & Equity	81,245	78,062	66,725	60,635	68,074	60,041
Total Debt	11,888	23,350	23,343	22,172	24,698	23,267
Net Cash (Debt)	-9,564	-18,663	-18,875	-20,544	-19,862	-21,629
Net Cash Per Share	-52.30	-103.18	-104.37	-113.59	-109.82	-119.60
Filing Date Shares Outstanding	188.36	181.15	180.85	180.85	180.85	180.85
Total Common Shares Outstanding	188.36	181.15	180.85	180.85	180.85	180.85
Working Capital	16,237	10,494	8,167	4,593	3,093	-2,168
Book Value Per Share	218.65	162.97	138.30	109.90	125.68	105.72
Tangible Book Value	31,155	20,658	21,576	16,088	14,923	10,192
Tangible Book Value Per Share	165.41	114.04	119.30	88.96	82.52	56.35
Land	-	526.46	533.22	522.55	42.28	27.45
Buildings	-	5,972	5,478	4,901	4,609	4,383
Machinery	-	25,498	20,713	18,271	17,526	15,096
Construction In Progress	-	1,323	4,035	3,098	2,216	3,319
Leasehold Improvements	-	564.89	368.83	324.63	1,798	1,848

Source: S&P Capital IQ. Standard template. Financial Sources.